Henderson Jeffrey William

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$350,430.00
Insider Sells Quantity
30
Insider Sells Sum
$144.52M

Insider Activity of Henderson Jeffrey William

According to the SEC Form 4 filings, Henderson Jeffrey William, being in a position of

  1. director at Becton, Dickinson and Company,
    оver the last 12 months, has bought 1500 shares for $350,430, and sold 0 shares,
    over all time since 2025-02-10, has bought 1500 shares for $350,430, and sold 0 shares.

The largest purchase of all time was on 2025-02-10 and amounted to 1500 shares of Becton, Dickinson and Company for $350,430.

The largest sale of all time was on 2014-02-03 and amounted to 506380 shares of Cardinal Health, Inc. for $34.02M.

Biography of Henderson Jeffrey William

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $350,430125
Sells
 $1,075,035375

Comparison of Insiders on Amount of Buys and Sells

2025-03-03SaleHalozyme Therapeutics, Inc.
HALO
director
5,000
0.0041%
$58.69$293,458+6.01%
2025-02-10PurchaseBecton, Dickinson and Company
BDX
director
1,500
0.0005%
$233.62$350,430-1.59%
2025-02-03SaleHalozyme Therapeutics, Inc.
HALO
director
5,000
0.0039%
$56.30$281,517+3.76%
2025-01-06SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0078%
$50.01$500,060+14.47%
2023-09-01SaleFibroGen, Inc.
FGEN
director
2,000
0.002%
$1.03$2,060-8.4%
2023-08-04SaleFibroGen, Inc.
FGEN
director
2,000
0.002%
$1.91$3,820-44.24%
2023-07-11SaleFibroGen, Inc.
FGEN
director
2,000
0.0021%
$2.69$5,380-58.61%
2023-06-08SaleFibroGen, Inc.
FGEN
director
7,000
0.0073%
$17.45$122,185-93.31%
2023-03-01SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0074%
$47.71$477,100-22.29%
2023-02-28SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0075%
$48.51$485,100-22.9%
2023-02-23SaleQUALCOMM Incorporated
QCOM
director
2,500
0.0002%
$124.19$310,469-3.83%
2023-02-22SaleQUALCOMM Incorporated
QCOM
director
2,500
0.0002%
$124.05$310,132-2.09%
2020-11-25SaleHalozyme Therapeutics, Inc.
HALO
director
24,498
0.0175%
$40.08$981,757+2.31%
2020-11-10SaleQUALCOMM Incorporated
QCOM
director
6,000
0.0005%
$141.10$846,602+1.14%
2014-08-27SaleCardinal Health, Inc.
CAH
Chief Financial Officer
53,134
0.0138%
$62.06$3.3M+17.82%
2014-08-18SaleCardinal Health, Inc.
CAH
Chief Financial Officer
157,274
0.0476%
$72.06$11.33M+18.52%
2014-08-08SaleCardinal Health, Inc.
CAH
Chief Financial Officer
236,186
0.0703%
$69.72$16.47M+20.06%
2014-07-14SaleCardinal Health, Inc.
CAH
Chief Financial Officer
47,264
0.0143%
$70.65$3.34M+17.65%
2014-05-07SaleCardinal Health, Inc.
CAH
Chief Financial Officer
54,062
0.0159%
$63.83$3.45M+24.52%
2014-02-03SaleCardinal Health, Inc.
CAH
Chief Financial Officer
506,380
0.1522%
$67.19$34.02M+10.78%
Total: 31
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.